C. Verhamme MD PhD publications

foto

Publications MD PhD C. Verhamme

Position
Medical Specialist
Main activities
Education, Patient care, Research
Specialisation
Neurology, clinical neurophysiology
Focus of research

The Department of Neurology performs clinical and translational research within three research themes: infection & inflammation, cerebrovascular disorders, and movement disorders. The themes are imbedded in the nine translational research programs of Amsterdam Neuroscience, the research institute of neuroscience investigators in the Amsterdam area. All staff members of the Department of Neurology are involved in research and collaborate within Neuroscience Amsterdam, with other academic and non-academic hospitals, and with international research groups.


Infection and inflammation. We perform clinical translational research in the field of neurological infections & inflammation. We perform prospective clinical cohort studies, randomized clinical trials, and experimental research, combining our clinical expertise with groundbreaking, translational approaches using clinical data, human samples, next generation sequencing, in vitro techniques, and mouse models in the era's of bacterial meningitis & encephalitis, infections after stroke, septic encephalopathy, and inflammatory diseases of peripheral nerves and muscles.


Neuromuscular disorders. Our neuromuscular centre is a NFU (Nederlandse federatie van universitaire medische centra) and ERN (European reference network) accredited center for neuromuscular diseases in general, and motor neuron disease (ALS), idiopathic inflammatory myopathy, poliomyelitis, hereditary neuropathies and inflammatory polyneuropathies in particular. Inflammatory diseases of peripheral nerves and muscles are the main focus of the neuromuscular research-line, within the research area neuro-infection and inflammation. The immune mediated neuropathies (e.g. GBS, CIDP, MMN) and idiopathic inflammatory myopathies (e.g. dermatomysositis, IBM) and critical illness neuropathy and myopathy are the specific diseases of interest. This research is patient-driven and translational. More specific, clinical trials, cohort studies and studies investigating immunological and genomic characterization of nerve and muscle inflammation are performed. From these studies we try to arrive at clinically relevant biomarkers of disease activity and predictors of response. For the critical illness neuromyopathies early predictors for disease and outcome are sought.
Improving the diagnostic and therapeutic options available to these patients are thus the starting point. The prevention of nerve and muscle damage and the improvement of the regenerative capacity are some of the key areas for the near future.

I am combining my position at the clinical neurophysiology with a neuromuscular outpatient clinic. Research topics are improving the diagnostic process for inflammatory neuropathies (CIDP, MMN and vasculitis), inflammatory myopathies (myositis) and critical illness neuromyopathy. The emphasis is on neurophysiological techniques, including nerve and muscle ultrasound. In collaboration with the department of radiology we are studying several MRI techniques to improve imaging of peripheral nerves including the plexus. Currently, we are also working on the start of a large national multicenter randomized clinical trial, in which we will compare initial surgical treatment with initial cortiocosteroid injection for carpal tunnel syndrome.

 

Amsterdam UMC Research Institutes
AMC departments
All publications

2020

  • Adrichem M. E., Bus S. R., Wieske L., Mohammed H., Verhamme C., Hadden R., van Schaik I. N., Eftimov F. Combined intravenous immunoglobulin and methylprednisolone as induction treatment in chronic inflammatory demyelinating polyneuropathy (OPTIC protocol): a prospective pilot study European journal of neurology 2020;27 (3):506-513 [PubMed]
  • Oudeman Jos, Eftimov Filip, Strijkers Gustav J., Schneiders Joppe J., Roosendaal Stefan D., Engbersen Maurits P., Froeling Martijn, Goedee H. Stephan, van Doorn Pieter A., Caan Matthan W. A., van Schaik Ivo N., Maas Mario, Nederveen Aart J., de Visser Marianne, Verhamme Camiel Diagnostic accuracy of MRI and ultrasound in chronic immune-mediated neuropathies Neurology 2020;94 (1):e62-e74 [PubMed]
  • Eftimov Filip, Lucke Ilse M., Querol Luis A., Rajabally Yusuf A., Verhamme Camiel Diagnostic challenges in chronic inflammatory demyelinating polyradiculoneuropathy Brain 2020;143 (11):3214-3224 [PubMed]
  • Witteveen Esther, Wieske Luuk, Sommers Juultje, Spijkstra Jan-Jaap, de Waard Monique C, Endeman Henrik, Rijkenberg Saskia, de Ruijter Wouter, Sleeswijk Mengalvio, Verhamme Camiel, Schultz Marcus J, van Schaik Ivo N, Horn Janneke Early Prediction of Intensive Care Unit-Acquired Weakness: A Multicenter External Validation Study Journal of intensive care medicine 2020;35 (6):595-605 [PubMed]
  • Oorschot Sander, Brehm Merel A., van Groenestijn Annerieke C., Koopman Fieke S., Verhamme Camiel, Eftimov Filip, Jelsma Judith G. M., Jorstad Harald T., Nollet Frans, Voorn Eric L. Efficacy of a physical activity programme combining individualized aerobic exercise and coaching to improve physical fitness in neuromuscular diseases (I'M FINE): study protocol of a randomized controlled trial BMC neurology 2020;20 (1):1-10 [PubMed]
  • Herraets Ingrid J. T., Goedee H. Stephan, Telleman Johan A., van Eijk Ruben P. A., Verhamme Camiel, Saris Christiaan G. J., Eftimov Filip, van Alfen Nens, van Asseldonk J. Thies, Visser Leo H., van den Berg Leonard H., van der Pol Ludo W. Nerve ultrasound for diagnosing chronic inflammatory neuropathy: A multicenter validation study Neurology 2020;95 (12):e1745-e1753 [PubMed]

2019

  • Lucke Ilse M., Wieske Luuk, van der Kooi Anneke J., van Schaik Ivo N., Eftimov Filip, Verhamme Camiel Diagnosis and treatment response in the asymmetric variant of chronic inflammatory demyelinating polyneuropathy Journal of the peripheral nervous system 2019;24 (2):174-179 [PubMed]
  • Bunschoten Carina, Eftimov Filip, van der Pol W. -Ludo, Jacobs Bart C., van Doorn P. A., Brusse E., Drenthen J., Arends S., Broers M. C., van Schaik I. N., van der Kooi A. J., Verhamme C., Adrichem M. E., van Lieverloo G. G. A., Lucke I. M., Bus S. R. M., van den Berg L. H., Notermans N. C., Vrancken A. F. J. E., Goedee H. S., Franssen H. International chronic inflammatory demyelinating polyneuropathy outcome study (ICOS): Protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome Journal of the peripheral nervous system 2019;24 (1):34-38 [PubMed]
  • Lucke Ilse M., Adrichem Max E., Wieske Luuk, van der Kooi Anneke J., Verhamme Camiel, van Schaik Ivo N., Eftimov Filip Intravenous immunoglobulins in patients with clinically suspected chronic immune-mediated neuropathy Journal of the neurological sciences 2019;397:141-145 [PubMed]
  • Tao Feifei, Beecham Gary W., Rebelo Adriana P., Blanton Susan H., Moran John J., Lopez-Anido Camila, Svaren John, Abreu Lisa, Rizzo Devon, Kirk Callyn A., Wu Xingyao, Feely Shawna, Verhamme Camiel, Saporta Mario A., Herrmann David N., Day John W., Sumner Charlotte J., Lloyd Thomas E., Li Jun, Yum Sabrina W., Taroni Franco, Baas Frank, Choi Byung-Ok, Pareyson Davide, Scherer Steven S., Reilly Mary M., Shy Michael E., Züchner Stephan Modifier gene candidates in charcot-marie-tooth disease type 1A: A case-only genome-wide association study Journal of neuromuscular diseases 2019;6 (2):201-211 [PubMed]
  • Telleman Johan A., Herraets Ingrid J. T., Goedee H. Stephan, Verhamme Camiel, Nikolakopoulos Stavros, van Asseldonk Jan-Thies H., van der Pol W. Ludo, van den Berg Leonard H., Visser Leo H. Nerve ultrasound: A reproducible diagnostic tool in peripheral neuropathy Neurology 2019;92 (5):E443-E450 [PubMed]
  • van Lieverloo Gwen G. A., Wieske Luuk, Verhamme Camiel, Vrancken Alexander F. J., van Doorn Pieter A., Michalak Zuzanna, Barro Christian, van Schaik Ivo N., Kuhle Jens, Eftimov Filip Serum neurofilament light chain in chronic inflammatory demyelinating polyneuropathy Journal of the peripheral nervous system 2019;24 (2):187-194 [PubMed]
  • Tao Feifei, Beecham Gary W., Rebelo Adriana P., Svaren John, Blanton Susan H., Moran John J., Lopez-Anido Camila, Morrow Jasper M., Abreu Lisa, Rizzo Devon, Kirk Callyn A., Wu Xingyao, Feely Shawna, Verhamme Camiel, Saporta Mario A., Herrmann David N., Day John W., Sumner Charlotte J., Lloyd Thomas E., Li Jun, Yum Sabrina W., Taroni Franco, Baas Frank, Choi Byung-Ok, Pareyson Davide, Scherer Steven S., Reilly Mary M., Shy Michael E., Züchner Stephan Variation in SIPA1L2 is correlated with phenotype modification in Charcot– Marie– Tooth disease type 1A Annals of neurology 2019;85 (3):316-330 [PubMed]

2018

  • van Lieverloo G. G. A., Peric S., Doneddu P. E., Gallia F., Nikolic A., Wieske L., Verhamme C., van Schaik I. N., Nobile-Orazio E., Basta I., Eftimov F. Corticosteroids in chronic inflammatory demyelinating polyneuropathy: A retrospective, multicentre study, comparing efficacy and safety of daily prednisolone, pulsed dexamethasone, and pulsed intravenous methylprednisolone Journal of neurology 2018;265 (9):2052-2059 [PubMed]
  • Oudeman Jos, Verhamme Camiel, Engbersen Maurits P., Caan Mattan W. A., Maas Mario, Froeling Martijn, Nederveen Aart J., Strijkers Gustav J. Diffusion tensor MRI of the healthy brachial plexus PLoS ONE 2018;13 (5) [PubMed]
  • Lucke Ilse M., Peric Stojan, van Lieverloo Gwen G. A., Wieske Luuk, Verhamme Camiel, van Schaik Ivo N., Basta Ivana, Eftimov Filip Elevated leukocyte count in cerebrospinal fluid of patients with chronic inflammatory demyelinating polyneuropathy Journal of the peripheral nervous system 2018;23 (1):49-54 [PubMed]
  • Weterman Marian A. J., Kuo Molly, Kenter Susan B., Gordillo Sara, Karjosukarso Dyah W., Takase Ryuichi, Bronk Marieke, Oprescu Stephanie, van Ruissen Fred, Witteveen Ron J. W., Bienfait Henriette M. E., Breuning Martijn, Verhamme Camiel, Hou Ya-Ming, de Visser Marianne, Antonellis Anthony, Baas Frank Hypermorphic and hypomorphic AARS alleles in patients with CMT2N expand clinical and molecular heterogeneities Human molecular genetics 2018;27 (23):4036-4050 [PubMed]
  • Witteveen Esther, Wieske Luuk, de Beer Friso M, Juffermans Nicole P, Verhamme Camiel, Schultz Marcus J, van Schaik Ivo N, Horn Janneke No association between systemic complement activation and intensive care unit-acquired weakness Annals of translational medicine 2018;6 (7):115 [PubMed]
  • ten Hoope Werner, Hollmann Markus W., de Bruin Kora, Verberne Hein J., Verkerk Arie O., Tan Hanno L., Verhamme Camiel, Horn Janneke, Rigaud Marcel, Picardi Susanne, Lirk Philipp Pharmacodynamics and pharmacokinetics of lidocaine in a rodent model of diabetic neuropathy Anesthesiology 2018;128 (3):609-619 [PubMed]

2017

  • Witteveen Esther, Sommers Juultje, Wieske Luuk, Doorduin Jonne, van Alfen Nens, Schultz Marcus J., van Schaik Ivo N., Horn Janneke, Verhamme Camiel Diagnostic accuracy of quantitative neuromuscular ultrasound for the diagnosis of intensive care unit-acquired weakness: a cross-sectional observational study Annals of intensive care 2017;7 (1):40 [PubMed]
  • Oudeman Jos Diffusion tensor imaging: A diagnostic tool for neuromuscular conditions 2017. 190p. ISBN 9789461828309. [UvA Dissertations Online] University of Amsterdam. (Supervisors: de Visser M., Maas M.; Co-supervisors: Verhamme C., Strijkers G. J., Nederveen A. J.)
  • Witteveen Esther, Wieske Luuk, van der Poll Tom, van der Schaaf Marike, van Schaik Ivo N., Schultz Marcus J., Verhamme Camiel, Horn Janneke, de Beer Friso M., Bos Lieuwe D. J., Glas Gerie J., van Hooijdonk Roosmarijn T. M., Hoogendijk Arie J., Huson Mischa A., Schouten Laura R. A., Straat Marleen, van Vught Lonneke A., Wiewel Maryse A. Increased Early Systemic Inflammation in ICU-Acquired Weakness; A Prospective Observational Cohort Study Critical care medicine 2017;45 (6):972-979 [PubMed]
  • Witteveen Esther Intensive care unit-acquired weakness: Pathophysiology and diagnosis 2017. 186p. ISBN 9789461828422. [UvA Dissertations Online] University of Amsterdam. (Supervisors: van Schaik I. N., Schultz M. J.; Co-supervisors: Horn J., Verhamme C.)
  • van Paassen Barbara W., Bronk Marieke, Verhamme Camiel, van Ruissen Fred, Baas Frank, van Spaendonck-Zwarts Karin Y., de Visser Marianne Pseudodominant inheritance pattern in a family with CMT2 caused by GDAP1 mutations Journal of the peripheral nervous system 2017;22 (4):464-467 [PubMed]

2016

  • Witteveen Esther, Hoogland Inge C. M., Wieske Luuk, Weber Nina C., Verhamme Camiel, Schultz Marcus J., van Schaik Ivo N., Horn Janneke Assessment of intensive care unit-acquired weakness in young and old mice: An E. coli septic peritonitis model Muscle & nerve 2016;53 (1):127-133 [PubMed]
  • Oudeman Jos, Coolen Bram F., Mazzoli Valentina, Maas Mario, Verhamme Camiel, Brink Wyger M., Webb Andrew G., Strijkers Gustav J., Nederveen Aart J. Diffusion-prepared neurography of the brachial plexus with a large field-of-view at 3T Journal of magnetic resonance imaging 2016;43 (3):644-654 [PubMed]
  • van der Tol Linda, Verhamme Camiel, van Schaik Ivo N., van der Kooi Anneke J., Hollak Carla E. M., Biegstraaten Marieke In Patients with an α-Galactosidase A Variant, Small Nerve Fibre Assessment Cannot Confirm a Diagnosis of Fabry Disease JIMD reports 2016;28:95-103 [PubMed]
  • ten Dam L., van der Kooi A. J., Verhamme C., Wattjes M. P., de Visser M. Muscle imaging in inherited and acquired muscle diseases European journal of neurology 2016;23 (4):688-703 [PubMed]

2015

  • Lirk P., Verhamme C., Boeckh R., Stevens M. F., ten Hoope W., Gerner P., Blumenthal S., de Girolami U., van Schaik I. N., Hollmann M. W., Picardi S. Effects of early and late diabetic neuropathy on sciatic nerve block duration and neurotoxicity in Zucker diabetic fatty rats British journal of anaesthesia 2015;114 (2):319-326 [PubMed]
  • Wieske Luuk, Verhamme Camiel, Witteveen Esther, Bouwes Aline, Dettling-Ihnenfeldt Daniela S., van der Schaaf Marike, Schultz Marcus J., van Schaik Ivo N., Horn Janneke Feasibility and diagnostic accuracy of early electrophysiological recordings for ICU-acquired weakness: an observational cohort study Neurocritical care 2015;22 (3):385-394 [PubMed]
  • Wieske Luuk, Dettling-Ihnenfeldt Daniela S., Verhamme Camiel, Nollet Frans, van Schaik Ivo N., Schultz Marcus J., Horn Janneke, van der Schaaf Marike Impact of ICU-acquired weakness on post-ICU physical functioning: a follow-up study Critical care (London, England) 2015;19 (1):196 [PubMed]
  • Wieske Luuk, van Hest Reinier M., Witteveen Esther, Verhamme Camiel, Schultz Marcus J., van Schaik Ivo N., Horn Janneke Is gentamicin affecting the neuromuscular system of critically ill patients? Intensive care medicine 2015;41 (4):727-728 [PubMed]
  • Engelen Marc, Barbier Mathieu, Dijkstra Inge M. E., Schür Remmelt, de Bie Rob M., Verhamme Camiel, Dijkgraaf Marcel G. W., Aubourg Patrick A., Wanders Ronald J. A., van Geel Bjorn M., de Visser Marianne, Poll-The Bwee T., Kemp Stephan Reply: Age-dependent penetrance among females with X-linked adrenoleukodystrophy Brain 2015;138 (2):e326 [PubMed]
  • Han Chongyang, Yang Yang, de Greef Bianca T. A., Hoeijmakers Janneke G. J., Gerrits Monique M., Verhamme Camiel, Qu Jian, Lauria Giuseppe, Merkies Ingemar S. J., Faber Catharina G., Dib-Hajj Sulayman D., Waxman Stephen G. The Domain II S4-S5 Linker in Nav1.9: A Missense Mutation Enhances Activation, Impairs Fast Inactivation, and Produces Human Painful Neuropathy Neuromolecular medicine 2015;17 (2):158-169 [PubMed]

2014

  • Eftimov Filip, Liesdek Marinus H., Verhamme Camillus, van Schaik Ivo N. Deterioration after corticosteroids in CIDP may be associated with pure focal demyelination pattern BMC neurology 2014;14 (1):72 [PubMed]
  • Wieske Luuk, Witteveen Esther, Verhamme Camiel, Dettling-Ihnenfeldt Daniela S., van der Schaaf Marike, Schultz Marcus J., van Schaik Ivo N., Horn Janneke Early prediction of intensive care unit-acquired weakness using easily available parameters: a prospective observational study PLoS ONE 2014;9 (10):e111259 [PubMed]
  • Wieske Luuk Intensive care unit-acquired weakness: early diagnosis, symptomatology and prognosis 2014. 173p. ISBN 9789461824417. [UvA Dissertations Online] University of Amsterdam. (Supervisors: van Schaik I. N., Schultz M. J.; Co-supervisors: Horn J., Verhamme C.)
  • Witteveen Esther, Wieske Luuk, Verhamme Camiel, Schultz Marcus J., van Schaik Ivo N., Horn Janneke Muscle and nerve inflammation in intensive care unit-acquired weakness: a systematic translational review Journal of the neurological sciences 2014;345 (1-2):15-25 [PubMed]
  • Wieske Luuk, Witteveen Esther, Petzold Axel, Verhamme Camiel, Schultz Marcus J., van Schaik Ivo N., Horn Janneke Neurofilaments as a plasma biomarker for ICU-acquired weakness: an observational pilot study Critical care (London, England) 2014;18 (1):R18 [PubMed]
  • van Paassen Barbara W., van der Kooi Anneke J., van Spaendonck-Zwarts Karin Y., Verhamme Camiel, Baas Frank, de Visser Marianne PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and Hereditary Neuropathy with liability to Pressure Palsies Orphanet journal of rare diseases 2014;9 (1):38 [PubMed]
  • van Schaik I. N., Verhamme C. Polyneuropathies: axonalin: D. Hilton-Jones, Martin R. Turner, editors. Oxford Textbook of Neuromuscular Disorders. S.l.: s.n.; 2014. p. 132-142, ISBN 9780199698073
  • Engelen Marc, Barbier Mathieu, Dijkstra Inge M. E., Schür Remmelt, de Bie Rob M. A., Verhamme Camiel, Dijkgraaf Marcel G. W., Aubourg Patrick A., Wanders Ronald J. A., van Geel Bjorn M., de Visser Marianne, Poll-The Bwee T., Kemp Stephan X-linked adrenoleukodystrophy in women: a cross-sectional cohort study Brain 2014;137 (Part 3):693-706 [PubMed]

2013

  • Wieske L., Chan Pin Yin D. R. P. P., Verhamme C., Schultz M. J., van Schaik I. N., Horn J. Autonomic dysfunction in ICU-acquired weakness: a prospective observational pilot study Intensive care medicine 2013;39 (9):1610-1617 [PubMed]
  • Wieske L., Kiszer E. R., Schultz M. J., Verhamme C., van Schaik I. N., Horn J. Examination of cardiovascular and peripheral autonomic function in the ICU: a pilot study Journal of neurology 2013;260 (6):1511-1517 [PubMed]

2011

  • de Visser Marianne, Verhamme Camiel Ascorbic acid for treatment in CMT1A: what's next? Lancet neurology 2011;10 (4):291-293 [PubMed]
  • Verhamme Camiel, King Rosalind H. M., ten Asbroek Anneloor L. M. A., Muddle John R., Nourallah Michelle, Wolterman Ruud, Baas Frank, van Schaik Ivo N. Myelin and Axon Pathology in a Long-Term Study of PMP22-Overexpressing Mice Journal of neuropathology and experimental neurology 2011;70 (5):386-398 [PubMed]
  • de Vries Sara D. J., Verhamme Camiel, van Ruissen Fred, van Paassen Barbara W., Arts Willem F., Kerkhoff Henk, van Engelen Baziel G. M., Lammens Martin, de Visser Marianne, Baas Frank, van der Kooi Anneke J. The phenotype of the Gly94fsX222 PMP22 insertion Journal of the peripheral nervous system 2011;16 (2):113-118 [PubMed]

2010

  • van Dijk J. P., Verhamme C., van Schaik I. N., Schelhaas H. J., Mans E., Bour L. J., Stegeman D. F., Zwarts M. J. Age-related changes in motor unit number estimates in adult patients with Charcot-Marie-Tooth type 1A European journal of neurology 2010;17 (8):1098-1104 [PubMed]
  • Verhamme Camiel Charcot-Marie-Tooth type 1A 2010. 181p. ISBN 9789081608114. [UvA Dissertations Online] University of Amsterdam. (Supervisors: de Visser M., Baas F.; Co-supervisor: van Schaik I. N.)
  • Videler Annemieke J., Beelen Anita, van Schaik Ivo N., Verhamme Camiel, van den Berg Leonard H., de Visser Marianne, Nollet Frans Tripod pinch strength and thumb opposition are the major determinants of manual dexterity in Charcot-Marie-Tooth disease type 1A Journal of neurology, neurosurgery, and psychiatry 2010;81 (8):828-833 [PubMed]

2009

  • Verhamme C., van Schaik I. N. Erfelijke polyneuropathieën: splitten of lumpen?in: N. Alfen van, A. L. Boerhaave, editors. Neuromusculaire aandoeningen: van ziekte naar gen naar genezing. S.l.: s.n.; 2009. p. 13, ISBN 9789067676564
  • Verhamme Camiel, de Haan Rob J., Vermeulen Marinus, Baas Frank, de Visser Marianne, van Schaik Ivo N. Oral high dose ascorbic acid treatment for one year in young CMT1A patients: a randomised, double-blind, placebo-controlled phase II trial BMC medicine 2009;7 (1):70 [PubMed]
  • Verhamme Camiel, van Schaik Ivo N., Koelman Johannes H. T. M., de Haan Rob J., de Visser Marianne The natural history of Charcot-Marie-Tooth type 1A in adults: a 5-year follow-up study Brain 2009;132 (Part 12):3252-3262 [PubMed]

2006

  • Bienfait Henriette M. E., Verhamme Camiel, van Schaik Ivo N., Koelman Johannes H. T. M., Ongerboer de Visser Bram W., de Haan Rob J., Baas Frank, van Engelen Baziel G. M., de Visser Marianne Comparison of CMT1A and CMT2: similarities and differences Journal of neurology 2006;253 (12):1572-1580 [PubMed]

2005

  • ten Asbroek Anneloor L. M. A., Verhamme Camiel, van Groenigen Marjon, Wolterman Ruud, de Kok-Nazaruk Maryla M., Baas Frank Expression profiling of sciatic nerve in a Charcot-Marie-Tooth disease type 1a mouse model Journal of neuroscience research 2005;79 (6):825-835 [PubMed]
  • Verhamme C., Baas F. Van gen naar ziekte; de ziekte van Charcot-Marie-Tooth ofwel de hereditaire motorische en sensorische neuropathieën Nederlands tijdschrift voor geneeskunde 2005;149 (27):1505-1509 [PubMed]

2004

  • Verhamme Camiel, van Schaik Ivo N., Koelman Johannes H. T. M., de Haan Rob J., Vermeulen Marinus, de Visser Marianne Clinical disease severity and axonal dysfunction in hereditary motor and sensory neuropathy Ia Journal of neurology 2004;251 (12):1491-1497 [PubMed]
back to MD PhD C. Verhamme